an update: joint commission standards and cms regulations or manager annual meeting john r. rosing,...
TRANSCRIPT
An Update: Joint Commission Standards and CMS Regulations
OR Manager Annual MeetingJohn R. Rosing, MHA, FACHE
Jennifer Cowel, RN, MBAPatton Healthcare Consulting
September 23, 2013Baltimore, Maryland
1
SpeakerJohn R. Rosing, MHA, FACHE
Accreditation and Regulatory Compliance Consultant
Vice President and Principal Patton Healthcare Consulting
262-242-3631
2
Sentinel Event Alert #49Safe Opioid Use - Risk Factors
• Hx of sleep apnea or snoring• Smoker• Morbid obesity• Older age (>80 has almost 9X > risk)• No recent opioid use///opioid habituation• Concomitant use of benzodiazepines, antihistamines,
sedatives or other CNS depressants• Post surgical, notably abdominal///thoracic• Longer anesthesia times• Pre-existing pulmonary or cardiac disease
3
Safe Opioid Use
• State Board of Medicine – Massachusetts– 27 incident reports since 2007– 77% concomitant morphine or lorazepam– 23% of patients were obese– 19% had sleep apnea– 15% asthma– 15% some other chronic respiratory condition– > age 60, female, most likely on night shift
4
Safe Opioid Use – Actions Taken• Eliminate range orders for dose and time• Lower dose hydromorphone purchased• Eliminate Pyxis override for hydromorphone• Educate staff on 8:1 dose conversion between
morphine and hydromorphone• Specific privileging for hydromorphone ordering• Discourage hydromorphone use for outpatients• Closely monitor patients with known risk factors
5
Safe Opioid Use - Key Recommendations
• Use conversion support systems when converting from one opioid to another or one route of administration to another.
• Use a sedation monitoring scale such as RASS, Pasero POSS or University of MI.
• As with any SEA, have paper trail showing consideration of recommendations and actions taken, plus subsequent QAPI
6
